COVID-19死亡患者肝脏病理:40例临床、组织学与病毒学数据
该研究分析40例死于COVID-19并发症患者的肝脏临床与组织学表现,并对部分肝组织块行PCR检测病毒RNA。结果示ALT中位峰值68 U/l、AST中位峰值102 U/l,大泡性脂肪变性最常见(30例,75%),轻度小叶性坏死性炎症和汇管区炎症各20例(50%),窦状微血栓6例(15%),肝组织PCR阳性11/20例(55%)。结论示死亡患者存在肝炎生化证据及大泡性脂肪变性、轻度急性肝炎和汇管区炎症,部分肝组织检出病毒RNA。
要点
- COVID-19死亡患者常见大泡性脂肪变性(75%)和轻度小叶性坏死性炎症/汇管区炎症(各50%)。
- 肝组织SARS-CoV-2 RNA PCR阳性率55%(11/20例),提示部分患者肝脏可检出病毒。
- 窦状微血栓等血管病理少见(15%),肝损伤以轻度急性肝炎模式为主。
核心结论
- 死于COVID-19的患者存在不同程度的肝炎生化证据,组织学以大泡性脂肪变性、轻度小叶性坏死性炎症和轻度汇管区炎症为主。
- 部分肝组织样本可检出SARS-CoV-2 RNA。
研究设计与样本
- 研究纳入40例死于COVID-19并发症的患者,报告肝脏相关临床与组织学表现。
- 对部分肝组织块行PCR检测病毒RNA。
主要发现
- ALT中位峰值68 U/l(正常上限46 U/l),AST中位峰值102 U/l(正常上限37 U/l)。
- 大泡性脂肪变性30例(75%),轻度小叶性坏死性炎症和汇管区炎症各20例(50%)。
- 窦状微血栓等血管病理6例(15%)。
- 肝组织PCR阳性11/20例(55%)。
临床怎么用
- 病理科医生在COVID-19死亡患者肝活检或尸检中应关注大泡性脂肪变性、轻度小叶性坏死性炎症和汇管区炎症。
- 肝组织PCR可辅助评估病毒RNA存在,但阳性率有限(55%),需结合临床与组织学综合判断。
局限性
- 仅对部分肝组织块行PCR检测(20例),病毒RNA数据有限。
- 为死亡患者系列,组织学发现与病毒RNA的因果关系未确立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The novel coronavirus SARS-CoV-2 (coronavirus disease 19, or COVID-19) primarily causes pulmonary injury, but has been implicated to cause hepatic injury, both by serum markers and histologic evaluation. The histologic pattern of injury has not been completely described. Studies quantifying viral load in the liver are lacking. Here we report the clinical and histologic findings related to the liver in 40 patients who died of complications of COVID-19. A subset of liver tissue blocks were subjected to polymerase chain reaction (PCR) for viral ribonucleic acid (RNA). Peak levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were elevated; median ALT peak 68 U/l (normal up to 46 U/l) and median AST peak 102 U/l (normal up to 37 U/l). Macrovesicular steatosis was the most common finding, involving 30 patients (75%). Mild lobular necroinflammation and portal inflammation were present in 20 cases each (50%). Vascular pathology, including sinusoidal microthrombi, was infrequent, seen in six cases (15%). PCR of liver tissue was positive in 11 of 20 patients tested (55%). In conclusion, we found patients dying of COVID-19 had biochemical evidence of hepatitis (of variable severity) and demonstrated histologic findings of macrovesicular steatosis and mild acute hepatitis (lobular necroinflammation) and mild portal inflammation. We also identified viral RNA in a sizeable subset of liver tissue samples.
引用
- Lagana SM, Kudose S, Iuga AC, et al. Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data. Mod Pathol. 2020. PMID: 32792598. doi:10.1038/s41379-020-00649-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。